얼굴용 주사제 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2035년)

Facial Injectables Market (Product Type: Dermal Fillers, Botulinum Toxin, Platelet-Rich Plasma, Deoxycholic Acid, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

US $ 5,795 ￦ 8,083,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,795 ￦ 12,268,000

PDF (Multi-user License)

PDF 보고서를 동일 부서 5명이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste가 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,795 ￦ 16,452,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

얼굴용 주사제 시장 - 분석 범위

TMR의 조사 보고서 "세계 얼굴용 주사제 시장"은 2025년부터 2035년까지의 예측 기간 동안 시장 지표에 대한 귀중한 인사이트를 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회도 조사했습니다. 이 보고서는 2019년부터 2035년까지 2019년을 기준 연도, 2035년을 예측 연도로 하여 2019년부터 2035년까지의 세계 얼굴용 주사제 시장의 수익과 예측을 제공합니다. 또한, 2025년부터 2035년까지 세계 얼굴용 주사제 시장의 연평균 성장률(CAGR, %)을 제시합니다.

이 보고서는 광범위한 조사를 통해 작성되었습니다. 1차 조사에서 분석가들은 주요 오피니언 리더, 업계 리더, 오피니언 메이커를 대상으로 인터뷰를 실시했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도자료, 관련 자료 등을 참조하여 얼굴용 주사제 시장을 추론하였습니다.

시장 개요
시장 규모(2024년)	103억 달러
시장 규모(2035년)	270억 달러
CAGR	9.2%

이 보고서는 세계 얼굴용 주사제 시장의 경쟁 환경을 분석합니다. 세계 얼굴용 주사제 시장에서 사업을 전개하는 주요 기업이 확인되었으며, 각 기업은 다양한 속성별로 프로파일링되어 있습니다. 기업 개요, 재무 상태, 최신 동향, SWOT는 본 보고서에서 소개하는 세계 얼굴용 주사제 시장의 각 기업의 속성입니다.

목차

제1장 서문

제2장 가정과 분석 방법

제3장 주요 요약 : 세계 시장

제4장 시장 개요

• 소개
• 개요
• 시장 역학
• 세계의 얼굴용 주사제 시장 분석과 예측(2020-2035년)

제5장 주요 인사이트

• 주요 업계 이벤트(사업 제휴·협력, 제품 승인, 기업 인수합병(M&A) )
• 제품/브랜드 분석
• 가격 분석
• 기술 진보
• PESTEL 분석
• 주요 국가·지역별 규제 시나리오
• Porter's Five Forces 분석
• 주요 국가별 상환 시나리오
• 최종사용자에 대한 주요 구입 지표
• 신규 시장 진입자를 위한 시장 개척 전략

제6장 세계 시장 분석과 예측 : 제품 종류별

• 소개·정의
• 주요 분석 결과/동향
• 시장 예측 : 제품 종류별(금액 기준, 2020-2035년)
  • 피부 충전제
    • 히알루론산(HA)
    • 칼슘하이드록시아파타이트(CaHA)
    • 폴리 L 젖산(PLLA)
    • 폴리메틸메타크릴레이트(PMMA)
    • 기타
  • 보툴리눔톡신(보톡스)
  • 혈소판풍부혈장(PRP)
  • 데옥시콜산
  • 기타
• 시장 매력 분석 : 제품 종류별

제7장 세계 시장 분석과 예측 : 성별

• 소개·정의
• 주요 분석 결과/동향
• 시장 예측 : 성별(금액 기준, 2020-2035년)
  • 남성
  • 여성
• 시장 매력 분석 : 성별

제8장 세계 시장 분석과 예측 : 용도별

• 소개·정의
• 주요 분석 결과/동향
• 시장 예측 : 용도별(금액 기준, 2020-2035년)
  • 페이스 라인 수정
  • 입술 확대
  • 흉터 치료
  • 페이스 리프트
  • 얼굴 볼륨 업
  • 기타
• 시장 매력 분석 : 용도별

제9장 세계 시장 분석과 예측 : 최종사용자별

• 소개·정의
• 주요 분석 결과/동향
• 시장 예측 : 최종사용자별(금액 기준, 2020-2035년)
  • 병원
  • 피부과 클리닉
  • 의료 스파
  • 기타
• 시장 매력 분석 : 최종사용자별

제10장 세계 시장 분석과 예측 : 지역별

• 주요 분석 결과
• 시장 예측 : 지역별(금액 기준, 2020-2035년)
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카
• 시장 매력 : 지역별

제11장 북미 시장 분석과 예측

제12장 유럽 시장 분석과 예측

제13장 아시아태평양 시장 분석과 예측

제14장 라틴아메리카 시장 분석과 예측

제15장 중동 및 아프리카 시장 분석과 예측

제16장 경쟁 구도

• 시장 기업·경쟁 매트릭스(기업 계층별·규모별)
• 시장 점유율 분석 : 기업별(2024년)
• 기업 개요
  • AbbVie Inc.(Allergan Aesthetics)
  • Anika Therapeutics, Inc.
  • Bioplus Co., Ltd.
  • BIOXIS Pharmaceuticals
  • Bloomage Biotech Co., Ltd
  • Galderma
  • Sinclair Pharma
  • Revance Therapeutics, Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Prollenium Medical Technologies Inc.
  • Teoxane SA
  • Croma-Pharma GmbH
  • Fidia Pharma USA Inc.
  • Tiger Aesthetics Medical, LLC

ksm

영문 목차

영문목차

Facial Injectables Market - Scope of Report

TMR's report on the global facial injectables market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global facial injectables market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global facial injectables market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the facial injectables market.

Market Snapshot
Market Value in 2024	US$ 10.3 Bn
Market Value in 2035	US$ 27 Bn
CAGR	9.2%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global facial injectables market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global facial injectables market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global facial injectables market.

The report delves into the competitive landscape of the global facial injectables market. Key players operating in the global facial injectables market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global facial injectables market profiled in this report.

Key Questions Answered in Global facial injectables market Report:

• What is the sales/revenue generated by apheresis across all regions during the forecast period?
• What are the opportunities in the global facial injectables market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Facial Injectables Market - Research Objectives and Research Approach

The comprehensive report on the global facial injectables market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global facial injectables market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global facial injectables market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Facial Injectables Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Facial Injectables Market Analysis and Forecast, 2020 to 2035
  • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

• 5.1. Key Industry Events (Partnerships, Collaborations, Product approvals, Mergers & Acquisitions)
• 5.2. Product/Brand Analysis
• 5.3. Pricing Analysis
• 5.4. Technological Advancements
• 5.5. PESTEL Analysis
• 5.6. Regulatory Scenario by Key Countries/Regions
• 5.7. Porter's Five Forces Analysis
• 5.8. Reimbursement Scenario by Key Countries
• 5.9. Key Purchase Metrics for End-users
• 5.10. Go-to-Market Strategy for New Market Entrants

6. Global Facial Injectables Market Analysis and Forecast, by Product Type

• 6.1. Introduction & Definition
• 6.2. Key Findings/Developments
• 6.3. Market Value Forecast, by Product Type, 2020 to 2035
  • 6.3.1. Dermal Fillers
    • 6.3.1.1. Hyaluronic acid (HA)
    • 6.3.1.2. Calcium hydroxylapatite (CaHA)
    • 6.3.1.3. Poly-L-lactic acid (PLLA)
    • 6.3.1.4. Polymethylmethacrylate (PMMA)
    • 6.3.1.5. Others
  • 6.3.2. Botulinum Toxin
  • 6.3.3. Platelet-Rich Plasma (PRP)
  • 6.3.4. Deoxycholic Acid
  • 6.3.5. Others
• 6.4. Market Attractiveness Analysis, by Product Type

7. Global Facial Injectables Market Analysis and Forecast, by Gender

• 7.1. Introduction & Definition
• 7.2. Key Findings/Developments
• 7.3. Market Value Forecast, by Gender, 2020 to 2035
  • 7.3.1. Male
  • 7.3.2. Female
• 7.4. Market Attractiveness Analysis, by Gender

8. Global Facial Injectables Market Analysis and Forecast, by Application

• 8.1. Introduction & Definition
• 8.2. Key Findings/Developments
• 8.3. Market Value Forecast, by Application, 2020 to 2035
  • 8.3.1. Facial Line Correction
  • 8.3.2. Lip Augmentation
  • 8.3.3. Scar Treatment
  • 8.3.4. Face Lift
  • 8.3.5. Facial Volume Enhancement
  • 8.3.6. Others
• 8.4. Market Attractiveness Analysis, by Application

9. Global Facial Injectables Market Analysis and Forecast, by End-user

• 9.1. Introduction & Definition
• 9.2. Key Findings/Developments
• 9.3. Market Value Forecast, by End-user, 2020 to 2035
  • 9.3.1. Hospitals
  • 9.3.2. Dermatology Clinics
  • 9.3.3. MedSpas
  • 9.3.4. Others
• 9.4. Market Attractiveness Analysis, by End-user

10. Global Facial Injectables Market Analysis and Forecast, by Region

• 10.1. Key Findings
• 10.2. Market Value Forecast, by Region, 2020 to 2035
  • 10.2.1. North America
  • 10.2.2. Europe
  • 10.2.3. Asia Pacific
  • 10.2.4. Latin America
  • 10.2.5. Middle East & Africa
• 10.3. Market Attractiveness By Region

11. North America Facial Injectables Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast, by Product Type, 2020 to 2035
  • 11.2.1. Dermal Fillers
    • 11.2.1.1. Hyaluronic acid (HA)
    • 11.2.1.2. Calcium hydroxylapatite (CaHA)
    • 11.2.1.3. Poly-L-lactic acid (PLLA)
    • 11.2.1.4. Polymethylmethacrylate (PMMA)
    • 11.2.1.5. Others
  • 11.2.2. Botulinum Toxin
  • 11.2.3. Platelet-Rich Plasma (PRP)
  • 11.2.4. Deoxycholic Acid
  • 11.2.5. Others
• 11.3. Market Value Forecast, by Gender, 2020 to 2035
  • 11.3.1. Male
  • 11.3.2. Female
• 11.4. Market Value Forecast, by Application, 2020 to 2035
  • 11.4.1. Facial Line Correction
  • 11.4.2. Lip Augmentation
  • 11.4.3. Scar Treatment
  • 11.4.4. Face Lift
  • 11.4.5. Facial Volume Enhancement
  • 11.4.6. Others
• 11.5. Market Value Forecast, by End-user, 2020 to 2035
  • 11.5.1. Hospitals
  • 11.5.2. Dermatology Clinics
  • 11.5.3. MedSpas
  • 11.5.4. Others
• 11.6. Market Value Forecast, by Country, 2020 to 2035
  • 11.6.1. U.S.
  • 11.6.2. Canada
• 11.7. Market Attractiveness Analysis
  • 11.7.1. By Product Type
  • 11.7.2. By Gender
  • 11.7.3. By Application
  • 11.7.4. By End-user
  • 11.7.5. By Country

12. Europe Facial Injectables Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast, by Product Type, 2020 to 2035
  • 12.2.1. Dermal Fillers
    • 12.2.1.1. Hyaluronic acid (HA)
    • 12.2.1.2. Calcium hydroxylapatite (CaHA)
    • 12.2.1.3. Poly-L-lactic acid (PLLA)
    • 12.2.1.4. Polymethylmethacrylate (PMMA)
    • 12.2.1.5. Others
  • 12.2.2. Botulinum Toxin
  • 12.2.3. Platelet-Rich Plasma (PRP)
  • 12.2.4. Deoxycholic Acid
  • 12.2.5. Others
• 12.3. Market Value Forecast, by Gender, 2020 to 2035
  • 12.3.1. Male
  • 12.3.2. Female
• 12.4. Market Value Forecast, by Application, 2020 to 2035
  • 12.4.1. Facial Line Correction
  • 12.4.2. Lip Augmentation
  • 12.4.3. Scar Treatment
  • 12.4.4. Face Lift
  • 12.4.5. Facial Volume Enhancement
  • 12.4.6. Others
• 12.5. Market Value Forecast, by End-user, 2020 to 2035
  • 12.5.1. Hospitals
  • 12.5.2. Dermatology Clinics
  • 12.5.3. MedSpas
  • 12.5.4. Others
• 12.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
  • 12.6.1. Germany
  • 12.6.2. UK
  • 12.6.3. France
  • 12.6.4. Italy
  • 12.6.5. Spain
  • 12.6.6. Rest of Europe
• 12.7. Market Attractiveness Analysis
  • 12.7.1. By Product Type
  • 12.7.2. By Gender
  • 12.7.3. By Application
  • 12.7.4. By End-user
  • 12.7.5. By Country/Sub-region

13. Asia Pacific Facial Injectables Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast, by Product Type, 2020 to 2035
  • 13.2.1. Dermal Fillers
    • 13.2.1.1. Hyaluronic acid (HA)
    • 13.2.1.2. Calcium hydroxylapatite (CaHA)
    • 13.2.1.3. Poly-L-lactic acid (PLLA)
    • 13.2.1.4. Polymethylmethacrylate (PMMA)
    • 13.2.1.5. Others
  • 13.2.2. Botulinum Toxin
  • 13.2.3. Platelet-Rich Plasma (PRP)
  • 13.2.4. Deoxycholic Acid
  • 13.2.5. Others
• 13.3. Market Value Forecast, by Gender, 2020 to 2035
  • 13.3.1. Male
  • 13.3.2. Female
• 13.4. Market Value Forecast, by Application, 2020 to 2035
  • 13.4.1. Facial Line Correction
  • 13.4.2. Lip Augmentation
  • 13.4.3. Scar Treatment
  • 13.4.4. Face Lift
  • 13.4.5. Facial Volume Enhancement
  • 13.4.6. Others
• 13.5. Market Value Forecast, by End-user, 2020 to 2035
  • 13.5.1. Hospitals
  • 13.5.2. Dermatology Clinics
  • 13.5.3. MedSpas
  • 13.5.4. Others
• 13.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
  • 13.6.1. China
  • 13.6.2. Japan
  • 13.6.3. India
  • 13.6.4. Australia & New Zealand
  • 13.6.5. Rest of Asia Pacific
• 13.7. Market Attractiveness Analysis
  • 13.7.1. By Product Type
  • 13.7.2. By Gender
  • 13.7.3. By Application
  • 13.7.4. By End-user
  • 13.7.5. By Country/Sub-region

14. Latin America Facial Injectables Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast, by Product Type, 2020 to 2035
  • 14.2.1. Dermal Fillers
    • 14.2.1.1. Hyaluronic acid (HA)
    • 14.2.1.2. Calcium hydroxylapatite (CaHA)
    • 14.2.1.3. Poly-L-lactic acid (PLLA)
    • 14.2.1.4. Polymethylmethacrylate (PMMA)
    • 14.2.1.5. Others
  • 14.2.2. Botulinum Toxin
  • 14.2.3. Platelet-Rich Plasma (PRP)
  • 14.2.4. Deoxycholic Acid
  • 14.2.5. Others
• 14.3. Market Value Forecast, by Gender, 2020 to 2035
  • 14.3.1. Male
  • 14.3.2. Female
• 14.4. Market Value Forecast, by Application, 2020 to 2035
  • 14.4.1. Facial Line Correction
  • 14.4.2. Lip Augmentation
  • 14.4.3. Scar Treatment
  • 14.4.4. Face Lift
  • 14.4.5. Facial Volume Enhancement
  • 14.4.6. Others
• 14.5. Market Value Forecast, by End-user, 2020 to 2035
  • 14.5.1. Hospitals
  • 14.5.2. Dermatology Clinics
  • 14.5.3. MedSpas
  • 14.5.4. Others
• 14.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
  • 14.6.1. Brazil
  • 14.6.2. Mexico
  • 14.6.3. Rest of Latin America
• 14.7. Market Attractiveness Analysis
  • 14.7.1. By Product Type
  • 14.7.2. By Gender
  • 14.7.3. By Application
  • 14.7.4. By End-user
  • 14.7.5. By Country/Sub-region

15. Middle East & Africa Facial Injectables Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value Forecast, by Product Type, 2020 to 2035
  • 15.2.1. Dermal Fillers
    • 15.2.1.1. Hyaluronic acid (HA)
    • 15.2.1.2. Calcium hydroxylapatite (CaHA)
    • 15.2.1.3. Poly-L-lactic acid (PLLA)
    • 15.2.1.4. Polymethylmethacrylate (PMMA)
    • 15.2.1.5. Others
  • 15.2.2. Botulinum Toxin
  • 15.2.3. Platelet-Rich Plasma (PRP)
  • 15.2.4. Deoxycholic Acid
  • 15.2.5. Others
• 15.3. Market Value Forecast, by Gender, 2020 to 2035
  • 15.3.1. Male
  • 15.3.2. Female
• 15.4. Market Value Forecast, by Application, 2020 to 2035
  • 15.4.1. Facial Line Correction
  • 15.4.2. Lip Augmentation
  • 15.4.3. Scar Treatment
  • 15.4.4. Face Lift
  • 15.4.5. Facial Volume Enhancement
  • 15.4.6. Others
• 15.5. Market Value Forecast, by End-user, 2020 to 2035
  • 15.5.1. Hospitals
  • 15.5.2. Dermatology Clinics
  • 15.5.3. MedSpas
  • 15.5.4. Others
• 15.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
  • 15.6.1. GCC Countries
  • 15.6.2. South Africa
  • 15.6.3. Rest of Middle East & Africa
• 15.7. Market Attractiveness Analysis
  • 15.7.1. By Product Type
  • 15.7.2. By Gender
  • 15.7.3. By Application
  • 15.7.4. By End-user
  • 15.7.5. By Country/Sub-region

16. Competition Landscape

• 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 16.2. Market Share Analysis, by Company (2024)
• 16.3. Company Profiles
  • 16.3.1. AbbVie Inc. (Allergan Aesthetics)
    • 16.3.1.1. Company Overview
    • 16.3.1.2. Financial Overview
    • 16.3.1.3. Product Portfolio
    • 16.3.1.4. Business Strategies
    • 16.3.1.5. Recent Developments
  • 16.3.2. Anika Therapeutics, Inc.
    • 16.3.2.1. Company Overview
    • 16.3.2.2. Financial Overview
    • 16.3.2.3. Product Portfolio
    • 16.3.2.4. Business Strategies
    • 16.3.2.5. Recent Developments
  • 16.3.3. Bioplus Co., Ltd.
    • 16.3.3.1. Company Overview
    • 16.3.3.2. Financial Overview
    • 16.3.3.3. Product Portfolio
    • 16.3.3.4. Business Strategies
    • 16.3.3.5. Recent Developments
  • 16.3.4. BIOXIS Pharmaceuticals
    • 16.3.4.1. Company Overview
    • 16.3.4.2. Financial Overview
    • 16.3.4.3. Product Portfolio
    • 16.3.4.4. Business Strategies
    • 16.3.4.5. Recent Developments
  • 16.3.5. Bloomage Biotech Co., Ltd
    • 16.3.5.1. Company Overview
    • 16.3.5.2. Financial Overview
    • 16.3.5.3. Product Portfolio
    • 16.3.5.4. Business Strategies
    • 16.3.5.5. Recent Developments
  • 16.3.6. Galderma
    • 16.3.6.1. Company Overview
    • 16.3.6.2. Financial Overview
    • 16.3.6.3. Product Portfolio
    • 16.3.6.4. Business Strategies
    • 16.3.6.5. Recent Developments
  • 16.3.7. Sinclair Pharma
    • 16.3.7.1. Company Overview
    • 16.3.7.2. Financial Overview
    • 16.3.7.3. Product Portfolio
    • 16.3.7.4. Business Strategies
    • 16.3.7.5. Recent Developments
  • 16.3.8. Revance Therapeutics, Inc.
    • 16.3.8.1. Company Overview
    • 16.3.8.2. Financial Overview
    • 16.3.8.3. Product Portfolio
    • 16.3.8.4. Business Strategies
    • 16.3.8.5. Recent Developments
  • 16.3.9. Merz Pharma GmbH & Co. KGaA
    • 16.3.9.1. Company Overview
    • 16.3.9.2. Financial Overview
    • 16.3.9.3. Product Portfolio
    • 16.3.9.4. Business Strategies
    • 16.3.9.5. Recent Developments
  • 16.3.10. Prollenium Medical Technologies Inc.
    • 16.3.10.1. Company Overview
    • 16.3.10.2. Financial Overview
    • 16.3.10.3. Product Portfolio
    • 16.3.10.4. Business Strategies
    • 16.3.10.5. Recent Developments
  • 16.3.11. Teoxane SA
    • 16.3.11.1. Company Overview
    • 16.3.11.2. Financial Overview
    • 16.3.11.3. Product Portfolio
    • 16.3.11.4. Business Strategies
    • 16.3.11.5. Recent Developments
  • 16.3.12. Croma-Pharma GmbH
    • 16.3.12.1. Company Overview
    • 16.3.12.2. Financial Overview
    • 16.3.12.3. Product Portfolio
    • 16.3.12.4. Business Strategies
    • 16.3.12.5. Recent Developments
  • 16.3.13. Fidia Pharma USA Inc.
    • 16.3.13.1. Company Overview
    • 16.3.13.2. Financial Overview
    • 16.3.13.3. Product Portfolio
    • 16.3.13.4. Business Strategies
    • 16.3.13.5. Recent Developments
  • 16.3.14. Tiger Aesthetics Medical, LLC
    • 16.3.14.1. Company Overview
    • 16.3.14.2. Financial Overview
    • 16.3.14.3. Product Portfolio
    • 16.3.14.4. Business Strategies
    • 16.3.14.5. Recent Developments

관련자료